Clofarex
Showing 1 - 25 of 40
Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia
Completed
- Acute Lymphoblastic Leukemia
- Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
- Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 26, 2022
Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)
Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,
Completed
- Disorder Related to Bone Marrow Transplantation
- +2 more
- Fludarabine
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 18, 2021
Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,
Completed
- Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood B-Lymphoblastic Lymphoma
- dexamethasone
- +18 more
-
San Diego, California
- +2 more
Sep 13, 2022
Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +6 more
- clofarabine
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Langerhans Cell Histiocytosis Trial in Canada, United States (Clofarabine)
Active, not recruiting
- Langerhans Cell Histiocytosis
-
Phoenix, Arizona
- +14 more
Mar 28, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine 40mg/m^2, Idarubicin
Completed
- Acute Myeloid Leukemia
- +2 more
- Clofarabine 40mg/m^2
- +5 more
-
Houston, TexasUT MD Anderson Cancer Center
Dec 3, 2020
Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +3 more
- Allogeneic Bone Marrow Transplantation
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Acute Myeloid Leukemia Trial in Singapore, United States (Cytarabine, Daunorubicin, Etoposide)
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell
Completed
- Acute Lymphoblastic Leukemia in Remission
- +6 more
- Allogeneic Bone Marrow Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Dec 15, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine, Busulfan, Fludarabine)
Completed
- Acute Myeloid Leukemia
- +2 more
- Clofarabine
- +5 more
-
Houston, TexasUT MD Anderson Cancer Center
Jan 6, 2021
Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,
Recruiting
- Acute Bilineal Leukemia
- +7 more
- Clofarabine
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Stem Cell Transplantation, Leukemia, Lymphoma Trial in Houston (Thiotepa, Clofarabine, Busulfan)
Completed
- Stem Cell Transplantation
- +2 more
- Thiotepa
- +9 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 25, 2020
Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +10 more
- Bortezomib
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2022
Myelodysplastic Syndrome, Leukemia Trial in Houston (procedure, drug, other, radiation)
Completed
- Myelodysplastic Syndrome
- Leukemia
- Cord Blood Infusion
- +11 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 27, 2020
Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)
Completed
- Leukemia
- Clofarabine
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 17, 2020
Acute Myeloid Leukemia Trial in Aurora, New Orleans, Seattle (procedure, drug, other, radiation)
Completed
- Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Aurora, Colorado
- +3 more
Apr 3, 2020
Acute Myelogenous Leukemia Trial in Houston (Plerixafor, Clofarabine)
Terminated
- Acute Myelogenous Leukemia
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 19, 2019
Leukemia Trial in Houston (Decitabine, Idarubicin, Cytarabine)
Completed
- Leukemia
- Decitabine
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 28, 2019
Leukemia Trial in Houston (drug, radiation, biological)
Active, not recruiting
- Leukemia
- Busulfan
- +11 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 22, 2019
Recurrent Aggressive Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Burkitt Lymphoma Trial in Houston
Not yet recruiting
- Recurrent Aggressive Non-Hodgkin Lymphoma
- +6 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Jan 6, 2020
Acute Lymphoblastic Leukemia, Lymphoma, Non-Hodgkin's, Leukemia, T-Cell Trial in Memphis (Dexamethasone, Panobinostat, Liposomal
Terminated
- Acute Lymphoblastic Leukemia
- +3 more
- Dexamethasone
- +13 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Mar 8, 2019
Acute Myeloid Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)
Completed
- Acute Myeloid Leukemia
- Clofarabine
- +2 more
-
Houston, TexasUT MD Anderson Cancer Center
Sep 10, 2018
Leukemia, Lymphoma, Allogeneic Haematopoietic Stem Cell Transplantation Trial in Houston (Busulfan, Clofarabine, Thymoglobulin)
Completed
- Leukemia
- +3 more
- Busulfan
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 11, 2018
Leukemia, Myeloproliferative Diseases Trial in Houston (Clofarabine, Cytarabine)
Completed
- Leukemia
- Myeloproliferative Diseases
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 5, 2018